Melatonin

This summary is currently (November 2016) being updated, please visit again at a later time.

History

“CAM-Cancer” was originally the name of a project entitled "Concerted Action for Complementary and Alternative Medicine Assessment in the Cancer Field" (CAM-Cancer).

“CAM-Cancer” was originally the name of a project entitled "Concerted Action for Complementary and Alternative Medicine Assessment in the Cancer Field" (CAM-Cancer).

How to communicate effectively about complementary, integrative and alternative medicine

Health professionals and cancer patients: how to communicate effectively about complementary, integrative and alternative medicine

By Anita Salamonsen, MSc, PhD1 and Moshe Frenkel, MD2,3

Mistletoe (Viscum album)

Photo: Mostphotos.com

                     Photo: Mostphotos.com

This summary is currently being updated. The version published here was last updated in January 2015.

Competence Network for Complementary Medicine in Oncology (KOKON)

Interdisciplinary network for CAM in oncology.

Interdisciplinary network for CAM in oncology.

European Organisation for Research and Treatment of Cancer

The aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to develop, conduct, coordinate, and stimulate translational and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patient quality of life. Extensive and comprehensive research in this wide field is often beyond the means of individual European hospitals, and can best be accomplished through the multidisciplinary multinational efforts of basic scientists and clinicians.

Danish Cancer Society

Aims

  • to prevent the development of cancer
  • to improve patients’ chances of successful recovery
  • to limit the physical, psychological and social side-effects of cancer

Main Fields of Activity

  • Research
  • Prevention
  • Patient support

Activities within CAM at the Danish Cancer Society

The main activities within CAM are:

The use of placebo in cancer research

Written by Vinjar Fønnebø and Edzard Ernst, and the CAM-Cancer Consortium. 
Updated March 11, 2011

Use of placebo in cancer research

By Vinjar Fønnebø, NAFKAM, University of Tromsø, Norway and Edzard Ernst, Complementary Medicine, Peninsula Medical School, Universities of Exeter & Plymouth, UK

When confronted with a cancer patient, the health professional faces several treatment challenges, some of them involve the use of CAM in one form or another.

AGSMO Arbeitsgemeinschaft Supportive Maßnahmen in der Onkologie der Deutschen Krebsgesellschaft, Germany

AGSMO is part of the German Cancer Society and has established a group which is in charge of the topic "CAM in supportive/rehabilitation oncology".

Chairs: Matthias Rostock and Markus Horneber

Competence Centre for Complementary Medicine and Naturopathy

The Centre for Complementary Medicine Research at the University Hospital ‘rechts der Isar’ of Technische Universität München can look back on more than 20 years of history. With effect from January 1, 2010, a chair of naturopathy and complementary medicine was established by the Faculty of Medicine, and Dieter Melchart, the longstanding leader of the centre, was appointed. It is the only position of this kind at the Bavarian universities and is funded by the Erich Rothenfußer Foundation.

NAFKAM -

Norway's National Research Center in Complementary and Alternative Medicine

We work to give you facts about complementary and alternative medicine, so that you can make safer choices for your health.

Read more about NAFKAM

Other websites from NAFKAM: